Zhejiang Starry Pharmaceutical Co., Ltd. Class ASSE: 603520

Announcement on Passing On-site Inspection by FDA

Nov 13, 2024 · Issued by Zhejiang Starry Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Passing On-site Inspection by FDA

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment